Pharmacokinetics of the angiotensin receptor-neprilysin inhibitor LCZ696 in furosemide-treated dogs

被引：0
|
作者：
Mochel, J. [1 ]
Seewald, W. [2 ]
Danhof, M. [3 ]
机构：
[1] Novartis Pharmaceut, Integrated Quantitat Sci, Basel, Switzerland
[2] Novartis, Elanco Anim Hlth, Dept Res & Dev, Basel, Switzerland
[3] Leiden Acad Ctr Drug Res, Dept Pharmacol, Leiden, Netherlands
来源：
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS | 2015年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
15.2
引用
收藏
页码：44 / 45
页数：2
相关论文
共 50 条
  • [1] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2017, 56 (12) : 1461 - 1478
  • [2] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor
    Surya Ayalasomayajula
    Thomas Langenickel
    Parasar Pal
    Sreedevi Boggarapu
    Gangadhar Sunkara
    Clinical Pharmacokinetics, 2017, 56 : 1461 - 1478
  • [3] Pharmacokinetics and Pharmacodynamics of LCZ696, a Novel Dual-Acting Angiotensin Receptor-Neprilysin Inhibitor (ARNi)
    Gu, Jessie
    Noe, Adele
    Chandra, Priya
    Al-Fayoumi, Suliman
    Ligueros-Saylan, Monica
    Sarangapani, Ramesh
    Maahs, Suzanne
    Ksander, Gary
    Rigel, Dean F.
    Jeng, Arco Y.
    Lin, Tsu-Han
    Zheng, Weiyi
    Dole, William P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (04): : 401 - 414
  • [4] Effects of age and sex on the pharmacokinetics of LCZ696, an angiotensin receptor neprilysin inhibitor
    Gan, Lu
    Langenickel, Thomas
    Petruck, Jesika
    Kode, Kiran
    Rajman, Iris
    Chandra, Priya
    Zhou, Wei
    Rebello, Sam
    Sunkara, Gangadhar
    JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 56 (01): : 78 - 86
  • [5] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Ayalasomayajula, Surya P.
    Langenickel, Thomas H.
    Jordaan, Pierre
    Zhou, Wei
    Chandra, Priyamvada
    Albrecht, Diego
    Pal, Parasar
    Rajman, Iris
    Sunkara, Gangadhar
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (09) : 1065 - 1073
  • [6] Renal protective effects and mechanisms of the angiotensin receptor-neprilysin inhibitor LCZ696 in mice with cardiorenal syndrome
    Li, Ying
    Kang, Li
    Rong, Kai
    Zhang, Yue
    Suo, Ya
    Yuan, Meng
    Bao, Qiankun
    Shao, Shuai
    Tse, Gary
    Li, Rong
    Liu, Tong
    Li, Guangping
    LIFE SCIENCES, 2021, 280
  • [7] Effect of renal function on the pharmacokinetics of LCZ696 (sacubitril/valsartan), an angiotensin receptor neprilysin inhibitor
    Surya P. Ayalasomayajula
    Thomas H. Langenickel
    Pierre Jordaan
    Wei Zhou
    Priyamvada Chandra
    Diego Albrecht
    Parasar Pal
    Iris Rajman
    Gangadhar Sunkara
    European Journal of Clinical Pharmacology, 2016, 72 : 1065 - 1073
  • [8] Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor-Neprilysin Inhibitor (vol 56, pg 1461, 2017)
    Ayalasomayajula, Surya
    Langenickel, Thomas
    Pal, Parasar
    Boggarapu, Sreedevi
    Sunkara, Gangadhar
    CLINICAL PHARMACOKINETICS, 2018, 57 (01) : 105 - 123
  • [9] Erratum to: Clinical Pharmacokinetics of Sacubitril/Valsartan (LCZ696): A Novel Angiotensin Receptor–Neprilysin Inhibitor
    Surya Ayalasomayajula
    Thomas Langenickel
    Parasar Pal
    Sreedevi Boggarapu
    Gangadhar Sunkara
    Clinical Pharmacokinetics, 2018, 57 : 105 - 123
  • [10] The angiotensin II receptor-neprilysin inhibitor LCZ696 attenuates the progression of proteinuria in type 2 diabetic rats
    Rahman, Asadur
    Sherajee, Shamshad J.
    Rafiq, Kazi
    Kobara, Hideki
    Masaki, Tsutomu
    Nakano, Daisuke
    Morikawa, Takashi
    Konishi, Yoshio
    Imanishi, Masahito
    Nishiyama, Akira
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2020, 142 (03) : 124 - 126
12345